Correlation Between Entero Therapeutics, and Johnson Johnson

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Johnson Johnson, you can compare the effects of market volatilities on Entero Therapeutics, and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Johnson Johnson.

Diversification Opportunities for Entero Therapeutics, and Johnson Johnson

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Entero and Johnson is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Johnson Johnson go up and down completely randomly.

Pair Corralation between Entero Therapeutics, and Johnson Johnson

Given the investment horizon of 90 days Entero Therapeutics, is expected to under-perform the Johnson Johnson. In addition to that, Entero Therapeutics, is 7.33 times more volatile than Johnson Johnson. It trades about -0.26 of its total potential returns per unit of risk. Johnson Johnson is currently generating about -0.27 per unit of volatility. If you would invest  16,345  in Johnson Johnson on August 23, 2024 and sell it today you would lose (888.00) from holding Johnson Johnson or give up 5.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Entero Therapeutics,  vs.  Johnson Johnson

 Performance 
       Timeline  
Entero Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.

Entero Therapeutics, and Johnson Johnson Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entero Therapeutics, and Johnson Johnson

The main advantage of trading using opposite Entero Therapeutics, and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.
The idea behind Entero Therapeutics, and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios